企業プロフィール
Bicycle Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- BCYC
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United Kingdom with U
株価パフォーマンス
4.00 USD (+2.56%)
終値
最終更新: 2026年8月17日
300M USD
時価総額
株価変動の要因
As of Aug 17, 2026, BCYC closed up 2.56% at $4.00. No new same-company headline was identified in the current news window.
企業概要
事業概要
Bicycle Therapeutics is a precision-oncology company focused on bicyclic peptide therapeutics and targeted cancer biology. Its platform seeks to pair selectivity with tumor targeting.
所在地とセクター分類
Headquartered in the United Kingdom with U.S. market exposure and listed on NASDAQ as an ADR, Bicycle is a global oncology biotech.
ビジネスモデルの特徴
The company depends on clinical data, platform validation, and the possibility of building a differentiated targeted-cancer franchise.
バイオ業界での位置付け
Bicycle is a high-quality platform oncology name whose valuation hinges on translational and clinical progress.
今後のカタリスト
- Bicycle Therapeutics's catalysts are BT8009 and BT5528, with oncology data driving whether the platform can still justify premium expectations. The next readout matters a lot because the platform story is still being judged.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。